Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Revisions of Precautions Required for 26 Ingredients
January 28, 2002
- JFMDA Prepares Guide on Handling of Used Medical Devices
January 28, 2002
- REGULATORY NEWS IN BRIEF
January 28, 2002
- RIKEN Invites Companies to Collaborate in Gene Polymorphism Analysis
January 28, 2002
- Kitasato Univ. Hospital Upgrades Immediate PMS System
January 28, 2002
- NanoCarrier Contracts with GSK for DDS
January 28, 2002
- Tsuruha: Sales Up 19.8%, Profits Up 27% in Semi-annual Results
January 28, 2002
- Theme for 2002 Baelz Prize Decided
January 28, 2002
- Kokuho Chuokai Welcomes On-line Applications for Reimbursement
January 28, 2002
- Switch to Marketing Approval to Increase Efficiency: FPMAJ President
January 28, 2002
- Link Staff Sets Up New Firm to Support Hospitals M&As
January 28, 2002
- Over 90% of JPMA Members to Prepare Compliance Programs: Survey
January 28, 2002
- Importance of Hospital Cost Management Stressed: Seminar
January 28, 2002
- Good Initial Market Reactions Reported for Eli Lilly's Humalog
January 28, 2002
- Sato Pharm to Accelerate Development of Switch OTC Drugs
January 28, 2002
- WEBSITE NEWS
January 28, 2002
- OTC NEWS IN BRIEF
January 28, 2002
- BUSINESS NEWS IN BRIEF
January 28, 2002
- Takara Obtains Rights for Cycling Probe Technique from IDB of Canada
January 28, 2002
- Meiji Seika to Concentrate on Infectious Diseases
January 21, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…